Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study

Combination of temozolomide (TMZ) and radiotherapy (RT) versus radiotherapy (RT) alone in newly diagnosed glioblastoma multiforme (GBM): A randomized phase II study

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(04)01139-3 ◽

2004 ◽

Vol 60 ◽

pp. S162-S163

Author(s):

H ATHANASSIOU ◽

M SYNODINOU ◽

E MARAGOUDAKIS ◽

M PARASKEVAIDIS ◽

C VERIGOS ◽

...

Keyword(s):

Glioblastoma Multiforme ◽

Phase Ii ◽

Phase Ii Study ◽

Newly Diagnosed ◽

Randomized Phase Ii ◽

Randomized phase II study of neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed primary glioblastoma multiforme.

10.1200/jco.2011.29.15_suppl.2052 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 2052-2052 ◽

Cited By ~ 1

Author(s):

K. F. Hofland ◽

S. Hansen ◽

M. Sorensen ◽

H. P. Schultz ◽

A. Muhic ◽

...

Keyword(s):

Glioblastoma Multiforme ◽

Phase Ii ◽

Phase Ii Study ◽

Newly Diagnosed ◽

Concomitant Chemoradiotherapy ◽

Primary Glioblastoma ◽

Randomized Phase Ii

Combination of temozolomide (TMZ) and radiotherapy (RT) versus radiotherapy (RT) alone in newly diagnosed glioblastoma multiforme (GBM): A randomized phase II study

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2004.06.082 ◽

2004 ◽

Vol 60 (1) ◽

pp. S162-S163

Author(s):

H. Athanassiou ◽

M. Synodinou ◽

E. Maragoudakis ◽

M. Paraskevaidis ◽

C. Verigos ◽

...

Keyword(s):

Glioblastoma Multiforme ◽

Phase Ii ◽

Phase Ii Study ◽

Newly Diagnosed ◽

Randomized Phase Ii ◽

Intensification of radiation therapy by temozolomide and fractionated stereotactic boost in newly diagnosed glioblastoma multiforme: A long-term analysis of a phase II study.

10.1200/jco.2010.28.15_suppl.e12515 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e12515-e12515

Author(s):

G. R. D'Agostino ◽

G. Chiloiro ◽

S. Manfrida ◽

S. Chiesa ◽

G. Apicella ◽

...

Keyword(s):

Radiation Therapy ◽

Glioblastoma Multiforme ◽

Phase Ii ◽

Phase Ii Study ◽

Newly Diagnosed ◽

Newly Diagnosed Glioblastoma ◽

Term Analysis

Outcomes following Conformal Fractionated Stereotactic Boost and Temozolomide in Newly Diagnosed Glioblastoma Multiforme: A Long Term Analyses of Phase II Study

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2010.07.620 ◽

2010 ◽

Vol 78 (3) ◽

pp. S260

Author(s):

M. Balducci ◽

G. Chiloiro ◽

S. Manfrida ◽

A. Mangiola ◽

G.R. D'Agostino ◽

...

Keyword(s):

Glioblastoma Multiforme ◽

Phase Ii ◽

Phase Ii Study ◽

Newly Diagnosed ◽

Faculty Opinions recommendation of Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.7871956.8220054 ◽

2011 ◽

Author(s):

Marc Chamberlain

Keyword(s):

Radiation Therapy ◽

Glioblastoma Multiforme ◽

Phase Ii ◽

Phase Ii Study ◽

Newly Diagnosed ◽

Phase II study of temozolomide (TMZ) administered on a 7 days on-7 days off regimen as primary treatment before radiotherapy (RT) in inoperable newly diagnosed glioblastoma multiforme (GBM)

10.1200/jco.2005.23.16_suppl.1523 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 1523-1523 ◽

Cited By ~ 4

Author(s):

O. Chinot ◽

M. Barrié ◽

A. Cournède ◽

H. Dufour ◽

D. Figarella-Branger ◽

...

Keyword(s):

Glioblastoma Multiforme ◽

Phase Ii ◽

Phase Ii Study ◽

Primary Treatment ◽

Newly Diagnosed ◽

Cilengitide in patients with newly diagnosed glioblastoma multiforme and unmethylated MGMT gene promoter: Protocol of a multicenter, randomized, open-label, controlled phase II study.

10.1200/jco.2010.28.15_suppl.tps151 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. TPS151-TPS151 ◽

Cited By ~ 5

Author(s):

L. B. Nabors ◽

K. Fink ◽

D. A. Reardon ◽

G. J. Lesser ◽

J. Trusheim ◽

...

Keyword(s):

Glioblastoma Multiforme ◽

Phase Ii ◽

Phase Ii Study ◽

Gene Promoter ◽

Newly Diagnosed ◽

Open Label ◽

Mgmt Gene ◽

Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations

Cancer ◽

10.1002/cncr.20224 ◽

2004 ◽

Vol 100 (10) ◽

pp. 2208-2214 ◽

Cited By ~ 113

Author(s):

Olivier-L. Chinot ◽

Maryline Barrie ◽

Elisabeth Frauger ◽

Henry Dufour ◽

Dominique Figarella-Branger ◽

...

Keyword(s):

Glioblastoma Multiforme ◽

Phase Ii ◽

Phase Ii Study ◽

Newly Diagnosed ◽

Elderly Populations ◽

Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme

Yearbook of Neurology and Neurosurgery ◽

10.1016/j.yneu.2012.05.009 ◽

2012 ◽

Vol 2012 ◽

pp. 105-106

Author(s):

J. Uhm

Keyword(s):

Radiation Therapy ◽

Glioblastoma Multiforme ◽

Phase Ii ◽

Phase Ii Study ◽

Newly Diagnosed ◽